login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
CODEXIS INC (CDXS) Stock News
USA
- NASDAQ:CDXS -
US1920051067
-
Common Stock
1.645
USD
+0.02 (+0.92%)
Last: 11/14/2025, 8:00:02 PM
1.64
USD
-0.01 (-0.3%)
After Hours:
11/14/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CDXS Latest News, Press Relases and Analysis
All
Press Releases
10 days ago - By: Chartmill
Codexis Inc (NASDAQ:CDXS) Plummets After Q3 2025 Revenue and Earnings Miss
10 days ago - By: Chartmill
- Mentions:
KRO
GMED
OLED
FOXF
...
What's going on in today's after hours session
5 days ago - By: Zacks Investment Research
Down 30% in 4 Weeks, Here's Why You Should You Buy the Dip in Codexis (CDXS)
6 days ago - By: Codexis, Inc.
Codexis Announces Signing of Lease for GMP Manufacturing Facility
9 days ago - By: Benzinga
- Mentions:
WORX
IRD
SINT
PPBT
...
12 Health Care Stocks Moving In Friday's After-Market Session
10 days ago - By: Benzinga
- Mentions:
MNOV
TNDM
GMED
WORX
...
12 Health Care Stocks Moving In Friday's Pre-Market Session
10 days ago - By: Zacks Investment Research
- Mentions:
BHST
Codexis (CDXS) Reports Q3 Loss, Misses Revenue Estimates
10 days ago - By: Codexis, Inc.
Codexis Reports Third Quarter 2025 Financial Results
12 days ago - By: Zacks Investment Research
- Mentions:
EYPT
EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Misses Revenue Estimates
12 days ago - By: Zacks Investment Research
- Mentions:
TARS
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Beats Revenue Estimates
18 days ago - By: Codexis
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing
25 days ago - By: Codexis, Inc.
Codexis to Report Third Quarter 2025 Financial Results on November 6
3 months ago - By: Codexis, Inc.
Codexis to Participate in Cantor Global Healthcare Conference
3 months ago - By: The Motley Fool
Codexis Revenue Jumps 91 Percent in Q2
3 months ago - By: Zacks Investment Research
- Mentions:
FENC
Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates
3 months ago - By: Codexis, Inc.
Codexis Reports Second Quarter 2025 Financial Results
3 months ago - By: Zacks Investment Research
- Mentions:
BTAI
BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Lags Revenue Estimates
3 months ago - By: Zacks Investment Research
- Mentions:
KYMR
Kymera Therapeutics, Inc. (KYMR) Reports Q2 Loss, Misses Revenue Estimates
3 months ago - By: Zacks Investment Research
- Mentions:
VRTX
Vertex Pharmaceuticals (VRTX) Surpasses Q2 Earnings and Revenue Estimates
4 months ago - By: Zacks Investment Research
- Mentions:
REGN
Regeneron (REGN) Tops Q2 Earnings and Revenue Estimates
4 months ago - By: Codexis, Inc.
Codexis to Report Second Quarter 2025 Financial Results on August 13
6 months ago - By: Codexis, Inc.
Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA
6 months ago - By: Codexis, Inc.
Codexis to Participate in Jefferies Global Healthcare Conference
6 months ago - By: Zacks Investment Research
- Mentions:
ROIV
Codexis (CDXS) Reports Q1 Loss, Misses Revenue Estimates
6 months ago - By: Codexis, Inc.
Codexis Reports First Quarter 2025 Financial Results
6 months ago - By: Zacks Investment Research
- Mentions:
IMNM
Immunome, Inc. (IMNM) Reports Q1 Loss, Tops Revenue Estimates
6 months ago - By: Codexis, Inc.
Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting
Please enable JavaScript to continue using this application.